Building out a robust competency-based training system requires more upfront planning and concentrated effort. It will allow ...
Have we passed the peak of biotech layoffs? It’s too early to say for certain—but an intriguing story is playing out in the ...
3d
Connect Biopharma touts rapid IV rademikibart FEV1 gains; Phase 3 atopic dermatitis data impresses
Connect Biopharma (NASDAQ:CNTB) shared new clinical and preclinical updates on rademikibart, its IL-4 receptor alpha ...
Biogen, Eli Lilly, Merck and Novartis spent more than $20 billion to absorb biotechs with promising or approved drugs; the ...
Biopharma funding fell 20% last year, reversing the post-pandemic recovery as the IPO haul dropped to the lowest level of the ...
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech ...
Funding from new and existing investors extends anticipated cash runway into the second half of 2027SAN DIEGO, March 30, 2026 (GLOBE NEWSWIRE) ...
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma ” or the “Company ”), a biopharmaceutical ...
InvestorsHub on MSN
Connect Biopharma shares jump after encouraging clinical data
Shares of Connect Biopharma Holdings Limited (NASDAQ:CNTB) climbed about 11% after the company released positive findings ...
The readout for Firmonertinib has moved to mid-2026, which may reflect slower event accumulation and potentially longer ...
View AEON Biopharma, Inc. Class A AEON stock quote prices, financial information, real-time forecasts, and company news from CNN.
View Aspire Biopharma Holdings, Inc. ASBP stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results